TD SYNNEX CapEx decreased by 13.4% to $33.15M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 20.2%, from $41.53M to $33.15M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 26.9% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.86M | $5.00M | $40.78M | $25.22M | $21.28M | $32.02M | $38.53M | $37.28M | $30.33M | $39.81M | $42.59M | $41.09M | $37.82M | $47.14M | $49.06M | $41.53M | $30.24M | $32.22M | $38.29M | $33.15M |
| QoQ Change | — | +2.8% | +716.1% | -38.2% | -15.6% | +50.4% | +20.3% | -3.2% | -18.6% | +31.2% | +7.0% | -3.5% | -7.9% | +24.6% | +4.1% | -15.4% | -27.2% | +6.5% | +18.8% | -13.4% |
| YoY Change | — | — | — | — | +337.9% | +540.8% | -5.5% | +47.8% | +42.5% | +24.3% | +10.5% | +10.2% | +24.7% | +18.4% | +15.2% | +1.1% | -20.0% | -31.7% | -21.9% | -20.2% |